184 related articles for article (PubMed ID: 25563681)
1. [Options for non-invasive assessment of liver fibrosis based on clinical data].
Egresi A; Lengyel G; Hagymási K
Orv Hetil; 2015 Jan; 156(2):43-52. PubMed ID: 25563681
[TBL] [Abstract][Full Text] [Related]
2. [Non-invasive assessment of fatty liver].
Egresi A; Lengyel G; Hagymási K
Orv Hetil; 2015 Apr; 156(14):543-51. PubMed ID: 25819147
[TBL] [Abstract][Full Text] [Related]
3. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
Sharma S; Khalili K; Nguyen GC
World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of hepatic fibrosis and cirrhosis].
Arends JE; de Knegt RJ; van Erpecum KJ; Hoepelman IM
Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1502-6. PubMed ID: 17763808
[TBL] [Abstract][Full Text] [Related]
6. Non invasive tools for the diagnosis of liver cirrhosis.
Soresi M; Giannitrapani L; Cervello M; Licata A; Montalto G
World J Gastroenterol; 2014 Dec; 20(48):18131-50. PubMed ID: 25561782
[TBL] [Abstract][Full Text] [Related]
7. Evolving strategies for liver fibrosis staging: Non-invasive assessment.
Stasi C; Milani S
World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
Malik R; Lai M; Sadiq A; Farnan R; Mehta S; Nasser I; Challies T; Schuppan D; Afdhal N
J Gastroenterol Hepatol; 2010 Sep; 25(9):1562-8. PubMed ID: 20796156
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
Cho SW; Cheong JY
Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
[TBL] [Abstract][Full Text] [Related]
10. [Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].
Pár A; Vincze Á; Pár G
Orv Hetil; 2015 May; 156(21):855-61. PubMed ID: 26038993
[TBL] [Abstract][Full Text] [Related]
11. [Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
Pár A; Pár G
Orv Hetil; 2010 Nov; 151(47):1951-5. PubMed ID: 21071307
[TBL] [Abstract][Full Text] [Related]
12. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
Cassinotto C; Lapuyade B; Mouries A; Hiriart JB; Vergniol J; Gaye D; Castain C; Le Bail B; Chermak F; Foucher J; Laurent F; Montaudon M; De Ledinghen V
J Hepatol; 2014 Sep; 61(3):550-7. PubMed ID: 24815876
[TBL] [Abstract][Full Text] [Related]
14. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.
Calès P; Boursier J; Ducancelle A; Oberti F; Hubert I; Hunault G; de Lédinghen V; Zarski JP; Salmon D; Lunel F;
Liver Int; 2014 Jul; 34(6):907-17. PubMed ID: 24102852
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
[TBL] [Abstract][Full Text] [Related]
16. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
Ogawa E; Furusyo N; Shimizu M; Ihara T; Hayashi T; Harada Y; Toyoda K; Murata M; Hayashi J
Antivir Ther; 2015; 20(2):185-92. PubMed ID: 24941012
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
de Lédinghen V; Le Bail B; Rebouissoux L; Fournier C; Foucher J; Miette V; Castéra L; Sandrin L; Merrouche W; Lavrand F; Lamireau T
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):443-50. PubMed ID: 18030211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
